Related Experiment Videos
How and when to use mitomycin-C in refractive surgery.
Gaston O Lacayo1, Parag A Majmudar
1Department of Ophthalmology, Rush University Medical Center, Chicago, Illinois, USA.
Current Opinion in Ophthalmology
|July 8, 2005
Summary
Mitomycin-C is an antimetabolite increasingly used in ophthalmology for managing scar and haze formation. It is a key tool in corneal wound healing after refractive surgery.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Wound Healing
Background:
- Mitomycin-C is an antimetabolite with growing applications in ophthalmology.
- It is utilized in glaucoma surgery and managing corneal disorders.
- Its role in scar and haze formation is well-established.
Purpose of the Study:
- To review the indications, techniques, and trends of Mitomycin-C application in corneal refractive surgery.
- To highlight Mitomycin-C's role in modulating corneal wound healing.
Main Methods:
- Literature review of Mitomycin-C applications in ophthalmology and refractive surgery.
- Analysis of current trends and techniques.
Main Results:
- Mitomycin-C is effective in managing scar and haze formation.
- It plays a significant role in corneal wound healing post-excimer laser ablation.
- Its use is expanding in refractive surgery.
Conclusions:
- Mitomycin-C is a valuable agent in corneal refractive surgery.
- Understanding its indications and techniques is crucial for optimal outcomes.
- Current trends indicate its continued importance in the field.